Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract 6177: Deciphering the molecular determinants of testosterone paradox in prostate cancer

Abhishek Shetty, Lillian Wilson, Deven Topiwala, Vaishnavi Anand, Zhen Wong, Yuhan Yang, Chandana Kruthiventi, Sai Harshitha Dakoor, Virginia Bencosme, Taylor Blanco, Boan Yang, Sayyada Kazim, Olutosin Owoyemi, Nathaniel Brennen, Eugene Shenderov, Michael Carducci, Samuel Denmeade, Sushant Kachhap

Cancer Res (2025) 85 (8_Supplement_1): 6177.

https://doi.org/10.1158/1538-7445.AM2025-6177

Published: 21 April 2025

View articletitled, Abstract 6177: Deciphering the molecular determinants of testosterone paradox in prostate cancer

Journal Articles

Abstract LB324: STING protein expression is increased in intermediate luminal cells in proliferative inflammatory atrophy of the prostate (PIA) and is absent in the majority of primary prostatic adenocarcinomas

Thomas M. Steele, Alan K. Meeker, Mindy K. Graham, Rulin Wang, Carolina Gomes-Alexandre, William G. Nelson, Fernanda Caramella Pereiria, Sushant Kachhap, Srinivasan Yegnasubramanian, Angelo Michael De Marzo

Cancer Res (2024) 84 (7_Supplement): LB324.

https://doi.org/10.1158/1538-7445.AM2024-LB324

Published: 05 April 2024

View articletitled, Abstract LB324: STING protein expression is increased in intermediate luminal cells in proliferative inflammatory atrophy of the prostate (PIA) and is absent in the majority of primary prostatic adenocarcinomas

Journal Articles

Abstract B067: CRM1 inhibitor selinexor induces DNA damage repair-related vulnerability in prostate cancer cells

Rajendra Kumar, Janet Mendonca, Yuhan Yang, Abhishek Shetty, Lillian Wilson, Kavya Boyapati, Deven Topiwala, Keerti Soundappan, Eleni Panagopoulos, Michael Carducci, Sushant Kachhap

Cancer Res (2023) 83 (11_Supplement): B067.

https://doi.org/10.1158/1538-7445.PRCA2023-B067

Published: 02 June 2023

View articletitled, Abstract B067: CRM1 inhibitor selinexor induces DNA damage repair-related vulnerability in prostate cancer cells

Journal Articles

Abstract 1600: Phase I trial of intravenous mistletoe extract in advanced cancer

Channing J. Paller, Lin Wang, Wei Fu, Rajedra Kumar, Jennifer Durham, Nilofer Azad, Daniel Laheru, Ilene Browner, Sushant Kachhap, Kavya Boyapati, Thomas Odeny, Deborah Armstrong, Christian Meyer, Stephanie Gaillard, Julie Brahmer, Ivelisse Page, Hao Wang, Luis A. Diaz

Cancer Res (2023) 83 (7_Supplement): 1600.

https://doi.org/10.1158/1538-7445.AM2023-1600

Published: 04 April 2023

View articletitled, Abstract 1600: Phase I trial of intravenous mistletoe extract in advanced cancer

Journal Articles

Abstract LB102: Effect of mistletoe extract on growth and proliferation of prostate cancer cells

Kavya Boyapati, Rajendra Kumar, Lillian Wilson, Yuhan Yang, Deven Topiwala, Keerti Soundappan, Eleni Panagopoulos, Ivelisse Page, Jennifer Durham, Michael Carducci, Channing Paller, Sushant Kachhap

Cancer Res (2021) 81 (13_Supplement): LB102.

https://doi.org/10.1158/1538-7445.AM2021-LB102

Published: 01 July 2021

View articletitled, Abstract LB102: Effect of mistletoe extract on growth and proliferation of prostate cancer cells

Journal Articles

Abstract 5084: Overcoming the resistance to anti-angiogenic therapy: Itraconazole blocks blood vessel maturation and synergizes with anti-VEGF therapy.

Chenglai Fu, Stephanie Gerber, Richmond Castillo, Anita van der Zwan, Sushant Kachhap, Hans Hammers

Cancer Res (2013) 73 (8_Supplement): 5084.

https://doi.org/10.1158/1538-7445.AM2013-5084

Published: 15 April 2013

View articletitled, Abstract 5084: Overcoming the resistance to anti-angiogenic therapy: Itraconazole blocks blood vessel maturation and synergizes with anti-VEGF therapy.

Journal Articles

Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment

John T. Isaacs, Lizamma Antony, Susan L. Dalrymple, W. Nathaniel Brennen, Stephanie Gerber, Hans Hammers, Michel Wissing, Sushant Kachhap, Jun Luo, Li Xing, Per Björk, Anders Olsson, Anders Björk, Tomas Leanderson

Cancer Res (2013) 73 (4): 1386–1399.

https://doi.org/10.1158/0008-5472.CAN-12-2730

Published: 14 February 2013

View articletitled, Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment

Includes: Supplementary data

Journal Articles

Abstract 1913: Epithelial mesenchymal transition: A mechanism of resistance to VEGF pathway inhibition in genitourinary cancers

Chenglai Fu, Stephanie Gerber, Susanna Van Den Berg, Frans Steenwinkel, Huub Kant, Whei Moriarty, Daniel Keizman, Luigi Marchionni, Michael Carducci, Georges Netto, Sushant Kachhap, Hans Hammers

Cancer Res (2012) 72 (8_Supplement): 1913.

https://doi.org/10.1158/1538-7445.AM2012-1913

Published: 15 April 2012

View articletitled, Abstract 1913: Epithelial mesenchymal transition: A mechanism of resistance to VEGF pathway inhibition in genitourinary cancers

Journal Articles

Abstract 2049: Preclinical profile of AMG900 in combination with HDACIs in prostate cancer

Channing Paller, Michel Wissing, Eugene Kim, Hans Hammers, Charles Rudin, Michael Carducci, Sushant Kachhap

Cancer Res (2012) 72 (8_Supplement): 2049.

https://doi.org/10.1158/1538-7445.AM2012-2049

Published: 15 April 2012

View articletitled, Abstract 2049: Preclinical profile of AMG900 in combination with HDACIs in prostate cancer

Journal Articles

Abstract 4701: Tasquinimod suppresses the adaptive stress response within sites of prostate cancer via disrupting zinc-dependent Histone Deacetylase 4 signaling.

Lizamma Antony, Susan Dalrymple, Stephanie Gerber, Hans Hammers, Sushant Kachhap, Per Bjork, Anders Olsson, Tomas Leanderson, John T. Isaacs

Cancer Res (2012) 72 (8_Supplement): 4701.

https://doi.org/10.1158/1538-7445.AM2012-4701

Published: 15 April 2012

View articletitled, Abstract 4701: Tasquinimod suppresses the adaptive stress response within sites of prostate cancer via disrupting zinc-dependent Histone Deacetylase 4 signaling.

Journal Articles

Abstract #5548: Involvement of E2F1 in down-regulation of homologous recombination repair genes upon histone deacetylase inhibition in prostate cancer

Sushant Kachhap, Spencer Collis, Madeleine Kortenhorst, Shabana Shabbeer, Luigi Marchionni, Jianqing Lin, Theodore Deweese, Michael Carducci

Cancer Res (2009) 69 (9_Supplement): 5548.

Published: 01 May 2009

View articletitled, Abstract #5548: Involvement of E2F1 in down-regulation of homologous recombination repair genes upon histone deacetylase inhibition in prostate cancer

Journal Articles

Elucidating the role of class I and class II histone deacetylases in regulation of NDRG1 in prostate cancer.

Sushant Kachhap, Justin DeAngelis, Shabana Shabbeer, Oscar Moradei, Amal Wahhab, Robert Deziel, Zuomei Li, Jianqing Lin, Robert Martell, Michael Carducci

Cancer Res (2008) 68 (9_Supplement): 748.

Published: 01 May 2008

View articletitled, Elucidating the role of class I and class II histone deacetylases in regulation of NDRG1 in prostate cancer.

Journal Articles

Defining the role of NDRG1 in prostate cancer

Sushant Kachhap, Dennis Faith, David Qian, Shabana Shabbeer, Nathan Galloway, Samuel Denmeade, Angelo DeMarzo, Michael Carducci

Cancer Res (2007) 67 (9_Supplement): 4934.

Published: 01 May 2007

View articletitled, Defining the role of NDRG1 in prostate cancer

Journal Articles

Gene set enrichment analysis of prostate cancer cells to study histone deacetylase inhibitor resistance

Madeleine Kortenhorst, Luigi Marchionni, Marianna Zahurak, Shabana Shabbeer, Sushant Kachhap, Giovanni Parmigiani, Henk Verheul, Michael Carducci

Cancer Res (2007) 67 (9_Supplement): 4416.

Published: 01 May 2007

View articletitled, Gene set enrichment analysis of prostate cancer cells to study histone deacetylase inhibitor resistance

Journal Articles

The anti-angiogenic effect of histone deacetylase inhibitors interfere with DNA methyl transferase inhibitor activity in vivo in prostate cancer models

Shabana Shabbeer, Madeleine Kortenhorst, Sushant Kachhap, Nathan Galloway, Michael Carducci

Cancer Res (2007) 67 (9_Supplement): 682.

Published: 01 May 2007

View articletitled, The anti-angiogenic effect of histone deacetylase inhibitors interfere with DNA methyl transferase inhibitor activity in vivo in prostate cancer models

Journal Articles

Multiple mechanisms explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

Shabana Shabbeer, Madeleine Kortenhorst, Sushant Kachhap, Nathan Galloway, Michael Carducci

Cancer Res (2006) 66 (8_Supplement): 1100.

Published: 15 April 2006

View articletitled, Multiple mechanisms explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

Journal Articles

Studies on 5-aza-2’-deoxycytidine in prostate cancer cells in vitro and in vivo

Shabana Shabbeer, Erica Washington, Sushant Kachhap, Madeleine Kortenhorst, Michael Carducci

Cancer Res (2005) 65 (9_Supplement): 771.

Published: 01 May 2005

View articletitled, Studies on 5-aza-2’-deoxycytidine in prostate cancer cells in vitro and in vivo

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 6177: Deciphering the molecular determinants of testosterone paradox in prostate cancer

Abstract LB324: STING protein expression is increased in intermediate luminal cells in proliferative inflammatory atrophy of the prostate (PIA) and is absent in the majority of primary prostatic adenocarcinomas

Abstract B067: CRM1 inhibitor selinexor induces DNA damage repair-related vulnerability in prostate cancer cells

Abstract 1600: Phase I trial of intravenous mistletoe extract in advanced cancer

Abstract LB102: Effect of mistletoe extract on growth and proliferation of prostate cancer cells

Abstract 5084: Overcoming the resistance to anti-angiogenic therapy: Itraconazole blocks blood vessel maturation and synergizes with anti-VEGF therapy.

Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment

Abstract 1913: Epithelial mesenchymal transition: A mechanism of resistance to VEGF pathway inhibition in genitourinary cancers

Abstract 2049: Preclinical profile of AMG900 in combination with HDACIs in prostate cancer

Abstract 4701: Tasquinimod suppresses the adaptive stress response within sites of prostate cancer via disrupting zinc-dependent Histone Deacetylase 4 signaling.

Abstract #5548: Involvement of E2F1 in down-regulation of homologous recombination repair genes upon histone deacetylase inhibition in prostate cancer

Elucidating the role of class I and class II histone deacetylases in regulation of NDRG1 in prostate cancer.

Defining the role of NDRG1 in prostate cancer

Gene set enrichment analysis of prostate cancer cells to study histone deacetylase inhibitor resistance

The anti-angiogenic effect of histone deacetylase inhibitors interfere with DNA methyl transferase inhibitor activity in vivo in prostate cancer models

Multiple mechanisms explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

Studies on 5-aza-2’-deoxycytidine in prostate cancer cells in vitro and in vivo

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only